|
Status |
Public on Sep 14, 2011 |
Title |
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis |
Organism |
Homo sapiens |
Experiment type |
Genome variation profiling by SNP array Expression profiling by array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
21876152 |
Submission date |
Nov 05, 2010 |
Last update date |
Dec 06, 2018 |
Contact name |
Nina Ilic |
E-mail(s) |
nina_ilic@dfci.harvard.edu
|
Phone |
617 632 6293
|
Fax |
617 632 4770
|
Organization name |
Dana-Farber Cancer Institute
|
Department |
Cancer Biology
|
Lab |
Roberts Laboratory-SM912
|
Street address |
44 Binney Street
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (2) |
GPL571 |
[HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array |
GPL3720 |
[Mapping250K_Sty] Affymetrix Mapping 250K Sty2 SNP Array |
|
Samples (12)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE25170 |
MYC drives resistance to PI3K/mTOR targeted inhibition (Sty SNP array) |
GSE25172 |
MYC drives resistance to PI3K/mTOR targeted inhibition (gene expression) |
|
Relations |
BioProject |
PRJNA134431 |